Kanglin Biotechnology has raised $20 million in financing to advance the development of sickle cell gene therapy KL003.
Health authorities in the Democratic Republic of Congo (DRC) are investigating the outbreak of a disease that has killed ...
The World Health Organization is sending a team into a rural southwest province of the DRC to investigate a recent outbreak ...
In a report released on December 3, Julian Harrison from BTIG maintained a Buy rating on Keros Therapeutics (KROS – Research Report), with a ...